Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

Abstract Introduction Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre‐direct‐acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor tolerance, and increased risk of allograft...

Full description

Bibliographic Details

Published in:	Immunity, Inflammation and Disease
Main Authors:	Mohamad M. Alkadi, Essa A. Abuhelaiqa, Mostafa F. Elshirbeny, Ahmed F. Hamdi, Omar M. Fituri, Muhammad Asim, Saad R. Alkaabi, Moutaz F. Derbala, Mona E. Jarman, Adel M. Ashour, Awais Nauman, Yousuf K. Al Maslamani, Adeel A. Butt, Hassan A. Al‐Malki
Format:	Article
Language:	English
Published:	Wiley 2021-03-01
Subjects:	hepatitis C immunosuppression kidney function kidney transplantation
Online Access:	https://doi.org/10.1002/iid3.386